Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

    Recruiting

    Belgium Bulgaria Czechia Hungary Italy Poland +1
  • Study of ruxolitinib cream for treating hidradenitis suppurativa in adult patients

    Recruiting

    1 1
    Investigated drugs:
    Bulgaria France Germany Italy Poland Spain
  • Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

    Recruiting

    1 1
    Investigated drugs:
    Belgium Bulgaria France Germany The Netherlands Poland +1
  • A study of futibatinib combined with tislelizumab, fluorouracil, calcium folinate, and oxaliplatin as first-line treatment for patients with colorectal cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

    Recruiting

    1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Ireland +2
  • Study of MK-1084, cetuximab and mFOLFOX6 combination compared to mFOLFOX6 with or without bevacizumab for patients with KRAS G12C-mutant advanced colorectal cancer

    Recruiting

    1 1 1 1
    Finland France Germany Hungary Italy The Netherlands +3
  • Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules

    Recruiting

    1 1 1 1
    Spain
  • Study of mirvetuximab soravtansine dosing schedules for patients with platinum-resistant advanced ovarian, peritoneal, or fallopian tube cancer with high folate receptor expression

    Recruiting

    1 1 1
    Belgium France Poland Spain
  • A study of Pseudovax, molgramostim and tislelizumab combination therapy for patients with pseudomyxoma peritonei cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Norway
  • Study of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness

    Recruiting

    1 1 1
    Belgium France Germany Italy Poland Portugal +1